Vanguard Investments Australia
MD icon

Vanguard Investments Australia’s Pediatrix Medical MD Stock Holding History

Vanguard Investments Australia’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$574K Buy
22,669
+2,157
+11% +$49.1K ﹤0.01% 1595
2026
Q1 		$439K Buy
+20,512
New +$427K ﹤0.01% 1636

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Investments Australia's MD Position: Q2 2026 in Review

Vanguard Investments Australia increased its Pediatrix Medical (MD) stake by 11% in Q2 2026, buying an estimated $49.1K and bringing the position to 22,669 shares worth $574K. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Vanguard Investments Australia first reported a position in MD in Q1 2026 and has held it in 2 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Vanguard Investments Australia held 22,669 shares of Pediatrix Medical worth $574K as of Q2 2026.
  • Vanguard Investments Australia bought 2,157 Pediatrix Medical shares in Q2 2026, an estimated $49.1K.
  • Pediatrix Medical made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1595 holding.
  • Vanguard Investments Australia first reported a position in Pediatrix Medical in Q1 2026 and has held it in 2 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.